A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Tributes have been paid to a young BBC Radio presenter who lost his battle with skin cancer aged just 33.
David Cameron is to put working people "front and centre" of his economic plan our economic plan" if the Conservatives win the election.
Nearly 38,000 runners will hope to complete Sunday's London Marathon making it the biggest event in its 35-year history.